COL11A1 Gene Fibrochondrogenesis type 1 Genetic Test
Test Name: COL11A1 Gene Fibrochondrogenesis type 1 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for COL11A1 Gene Fibrochondrogenesis type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL11A1 Gene Fibrochondrogenesis type 1 NGS Genetic DNA Test gene COL11A1
Test Details
The COL11A1 gene is associated with a rare genetic disorder called fibrochondrogenesis type 1. This disorder affects the development of connective tissues, particularly those found in cartilage and bone. It is characterized by short stature, joint abnormalities, and distinctive facial features.
NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that can analyze multiple genes simultaneously. In the context of genetic testing for fibrochondrogenesis type 1, NGS can be used to identify mutations or variations in the COL11A1 gene that may be responsible for the disorder.
Genetic testing for fibrochondrogenesis type 1 using NGS involves obtaining a DNA sample from the individual being tested, typically through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the COL11A1 gene. This information can help diagnose the disorder and provide valuable information for genetic counseling and management of the condition.
It’s important to note that genetic testing for fibrochondrogenesis type 1 is typically performed by healthcare professionals with expertise in genetics. They can provide guidance on the appropriateness of testing, interpretation of results, and implications for individuals and their families.
| Test Name | COL11A1 Gene Fibrochondrogenesis type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for COL11A1 Gene Fibrochondrogenesis type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL11A1 Gene Fibrochondrogenesis type 1 NGS Genetic DNA Test gene COL11A1 |
| Test Details |
The COL11A1 gene is associated with a rare genetic disorder called fibrochondrogenesis type 1. This disorder affects the development of connective tissues, particularly those found in cartilage and bone. It is characterized by short stature, joint abnormalities, and distinctive facial features. NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that can analyze multiple genes simultaneously. In the context of genetic testing for fibrochondrogenesis type 1, NGS can be used to identify mutations or variations in the COL11A1 gene that may be responsible for the disorder. Genetic testing for fibrochondrogenesis type 1 using NGS involves obtaining a DNA sample from the individual being tested, typically through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the COL11A1 gene. This information can help diagnose the disorder and provide valuable information for genetic counseling and management of the condition. It’s important to note that genetic testing for fibrochondrogenesis type 1 is typically performed by healthcare professionals with expertise in genetics. They can provide guidance on the appropriateness of testing, interpretation of results, and implications for individuals and their families. |
